Close Menu

Case Western and UNC researchers used phage display and molecular modeling to identify a binding ligand with high affinity for CRIP1, or cysteine-rich intestinal protein 1, which is a novel biomarker for early detection of breast cancer. After modelling and synthesizing a new peptide, A1M, they found that A1M had a 10 to 28-fold improvement in binding affinity than the original sequence motifs from the phage display work.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.